Milford

State public health officials on Friday announced 11 approved medical marijuana dispensaries – including two in Central Massachusetts - will move to the inspectional phase after completing a verification level that included background checks.

As school shootings continue to make headlines, public school systems are investing in security systems to make students safer in the Bay State and beyond. One Framingham company is beginning to make inroads with a new mobile app that gives school officials fast access to public safety, with the click of a cell phone button. Rave Mobile Safety launched its Rave Panic Button mobile software on June 16 - incidentally, about a week after the nation's latest school shooting in Troutdale, Ore.

A neonatal screening device made by Milford-based Waters Corp. has secured regulatory approval in China, clearing the way for promotion and sale in that country, the company announced.

A Cape Cod man has purchased a medical office building in Milford for $5.85 million.

Entrepreneur Dorian A. Des Lauriers, ProVerde Laboratories' CEO, teamed up with Christopher Hudalla, the company's chief scientific...

Slower growth in Asia and a delay in the release of corporate capital budgets in the United States resulted in flat revenue growth for Milford-based Waters Corp. in the first quarter, the laboratory instrument manufacturer said today.

Milford-based Atlas Travel has expanded to the United Kingdom, opening a new office in London, the company said.

Construction of a new wing at Milford Regional Medical Center is underway, and while the hospital's new emergency department and intensive care units will house state-of-the-art technology and boast more square footage, the availability of more private rooms may be even more attractive to prospective patients. According to hospital administrators, new construction projects at Massachusetts hospitals must feature only single-patient rooms. That measure is designed to decrease the risk of contagion between patients and increase patient privacy, which has become increasingly important under state and federal laws governing medical privacy.

Milford-based Waters Corp. is investing in an Irish research facility that's developing a test to predict premature births in expectant mothers.

Dorian Des Lauriers, co-founder and president of ProVerde Laboratories Inc., is a self-described “chronic entrepreneur,” and his latest venture brings him into the uncharted territory of the Massachusetts' budding medical marijuana industry. ProVerde will conduct testing on medical marijuana, among other specimens, at its new Milford site on Fortune Boulevard. By providing testing services, Des Lauriers hopes to legitimize the substance as a treatment for those with chronic illness and remove the perception that marijuana is just a recreational drug.